PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: IMARC Group

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Global Biotechnology Market Expected to Undergo a Number of Transformations Finds IMARC Group - The biotechnology market is undergoing a number of transformations. These include a shift of growth towards emerging markets, increasing focus on monoclonal antibodies and an increasing penetration of biosimilars - IMARCgroup.com
Global Biotechnology Market Expected to Undergo a Number of Transformations Finds IMARC Group

 

NewswireToday - /newswire/ - Ghaziabad, Uttar Pradesh, India, 2013/04/19 - The biotechnology market is undergoing a number of transformations. These include a shift of growth towards emerging markets, increasing focus on monoclonal antibodies and an increasing penetration of biosimilars - IMARCgroup.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The global biotechnology market is expected to grow at a CAGR of 7% during 2013-2017 reaching sales worth nearly US$ 166 billion by 2017. This market, however, is expected to undergo a number of transformations which would impact the course of its growth. These transitions include a shift of growth from the developed to the emerging markets, an increasing focus on monoclonal antibodies compared to therapeutic proteins and an increasing penetration of biosimilars/follow-on-biologics compared to their branded versions. As a result of these transformations, the need for a user friendly, robust and comprehensive biotechnology market intelligence has become imperative for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the biotechnology market in some form or the other.

IMARC Group, one of the world’s leading research and advisory firms, introduces a new and revolutionary way to understand and evaluate the global biotechnology market with its new report entitled “Global Biopharmaceutical Market Report & Forecast: 2012-2017”. This report provides an analytical and statistical insight into the global biotechnology market. The study, which has been undertaken using desk based as well as primary market research is a must for: pharmaceutical manufacturers, biopharmaceutical manufacturers, drug delivery device manufacturers, PE firms, FDI investors, planning agencies, consultants, research firms, credit rating agencies, etc.

Regions/Countries Covered:
• North America: United States and Canada
• Latin America: Mexico, Brazil and Argentina
• Europe: Germany, France, Italy, Spain, United Kingdom, Russia and Turkey
• Asia Pacific: Japan, China, Australia, South Korea, India and Indonesia

Table of Contents
1. Market Definitions & Research Methodology
2. Analyst Briefing
3. Introduction to Biopharmaceuticals
4. Global Biopharmaceutical Market: Industry Analysis
4.1 Strengths
4.2 Weaknesses
4.3 Opportunities
4.4 Threats
5. Global Biopharmaceutical Market: Industry Performance
5.1 Market Performance & Forecast
5.2 Market Segmentation by Region
5.3 Market Segmentation by Indication
5.4 Market Segmentation by Class
6. North America
6.1 US
6.2 Canada
7. Latin America
7.1 Mexico
7.2 Brazil
7.3 Argentina
8. Europe
8.1 Germany
8.2 France
8.3 Italy
8.4 Spain
8.5 UK
8.6 Russia
8.7 Turkey
9. Asia Pacific
9.1 Japan
9.2 China
9.3 Australia
9.4 South Korea
9.5 India
9.6 Indonesia

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: IMARC Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Global Biotechnology Market Expected to Undergo a Number of Transformations Finds IMARC Group

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Krishna Sharma - IMARCgroup.com 
+91 12 04155099 press[.]imarcgroup.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IMARC Group securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From IMARC Group / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)